Monoclonal antibody AER002 fails to ease Long COVID symptoms in first randomized mechanistic trial
A randomized phase 2a trial found the SARS-CoV-2 monoclonal antibody AER002 safe but ineffective for Long COVID overall, though post-hoc ...
A randomized phase 2a trial found the SARS-CoV-2 monoclonal antibody AER002 safe but ineffective for Long COVID overall, though post-hoc ...
A study of 79 African lakes shows that methane-oxidizing bacteria, boosted by phytoplankton and wetland inputs, consume more than 70 ...
Researchers have coupled a MOF-303 atmospheric water harvester to a discharging battery so that waste heat regenerates the sorbent while ...
A new genomic survey of the Clarion-Clipperton Fracture Zone reveals that over 99 percent of its sediment viruses are unknown ...
A new Nature Communications Comment argues that Türkiye's 2018 building inspection reform displaced rather than transferred accountability, helping explain why ...
A new analysis of more than 90,000 documents shows the Antarctic Treaty System converts internal threats into governance action but ...
A foundation model-based AI system called WeedNet identifies 1,593 weed species with 91.02 percent accuracy and reaches 97.38 percent accuracy ...
A phase II pilot trial found that a single fecal microbiota transplantation combined with atezolizumab and bevacizumab was safe and ...
A new Nature Communications study estimates that maize-soybean intercropping on up to 20 million hectares could cover three-quarters of the ...
A new re-analysis and replication study in Nature Communications argues that the famous 'Angry Blueberries' experiment did not demonstrate an ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine